Perspective Therapeutics (CATX) Inventory Average (2016 - 2023)

Perspective Therapeutics (CATX) has disclosed Inventory Average for 12 consecutive years, with $1.1 million as the latest value for Q3 2023.

  • Quarterly Inventory Average fell 28.55% to $1.1 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Sep 2023, down 28.55% year-over-year, with the annual reading at $1.4 million for FY2022, N/A changed from the prior year.
  • Inventory Average hit $1.1 million in Q3 2023 for Perspective Therapeutics, down from $1.3 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.5 million in Q4 2022 to a low of $513500.0 in Q1 2019.
  • Historically, Inventory Average has averaged $908184.2 across 5 years, with a median of $855500.0 in 2021.
  • Biggest five-year swings in Inventory Average: soared 62.94% in 2021 and later dropped 28.55% in 2023.
  • Year by year, Inventory Average stood at $523000.0 in 2019, then rose by 24.86% to $653000.0 in 2020, then skyrocketed by 62.94% to $1.1 million in 2021, then skyrocketed by 39.19% to $1.5 million in 2022, then decreased by 28.87% to $1.1 million in 2023.
  • Business Quant data shows Inventory Average for CATX at $1.1 million in Q3 2023, $1.3 million in Q2 2023, and $1.4 million in Q1 2023.